Aragen and CEVEC Sign License Agreement for Human CAP® and CAP-T™ Technology

News   May 05, 2010

 
Aragen and CEVEC Sign License Agreement for Human CAP® and CAP-T™ Technology
 
 
 

RELATED ARTICLES

Video Database for Cellular Tracking Created

News

Researchers have developed a video database for cellular tracking that can be used to determine alterations involved in illnesses such as cancer.

READ MORE

Eppendorf Hosts Second Stem Cell Community Day in Duesseldorf

News

The event brings together experts from industry and academia to discuss recent trends, achievements, and challenges in bioprocessing technologies for stem cell research. The conference is organized by leading life science company Eppendorf AG.

READ MORE

Algorithm Unearths Over 1000 Antibiotic Proteins in a Few Hours

News

The algorithm identified 10 times more peptide variations than all previous discoveries combined, aiding the hunt for new antibiotics.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE